ArticleInvestigational new drugs2019

Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity.

Lisa M Oppegard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.